Strong subsite‐specific variation in detecting advanced adenomas by fecal immunochemical testing for hemoglobin

No abstract is available for this paper.

• Publication year

  2017

• Venue

  International Journal of Cancer

• Publication date

  2017-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ijc.30629PMID 28152558
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial.

  2019cited by this paper
• Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer

  2017cited by this paper
• Diagnostic Accuracy of a Qualitative Fecal Immunochemical Test Varies With Location of Neoplasia But Not Number of Specimens.

  2015cited by this paper
• Trends in Adenoma Detection Rates During the First 10 Years of the German Screening Colonoscopy Program.

  2015cited by this paper
• Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know

  2015cited by this paper
• Head-to-Head Comparison and Evaluation of 92 Plasma Protein Biomarkers for Early Detection of Colorectal Cancer in a True Screening Setting

  2015cited by this paper
• Which adenomas are detected by fecal occult blood testing? A state‐wide analysis from Bavaria, Germany

  2015cited by this paper
• Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial.

  2014cited by this paper
• Colorectal Cancer Screening: Tests, Strategies, and Perspectives

  2014cited by this paper
• R: A language and environment for statistical computing.

  2014cited by this paper
• Multitarget stool DNA testing for colorectal-cancer screening.

  2014cited by this paper
• A standard for Faecal Immunochemical TesTs for Haemoglobin Evaluation Reporting (FITTER)

  2014cited by this paper
• Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies

  2014influential reference
• Multitarget stool DNA testing for colorectal-cancer screening.

  2014cited by this paper
• Association between early stage colon neoplasms and false-negative results from the fecal immunochemical test.

  2013cited by this paper
• Comparative Effectiveness and Cost-Effectiveness of Screening Colonoscopy vs. Sigmoidoscopy and Alternative Strategies

  2013cited by this paper
• Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.

  2013cited by this paper
• Immunochemical Fecal Occult Blood Testing Is Equally Sensitive for Proximal and Distal Advanced Neoplasia

  2012cited by this paper
• Low-Dose Aspirin Use and Performance of Immunochemical Fecal Occult Blood Tests

  2012cited by this paper
• Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.

  2012cited by this paper
• Test Performance of Immunologic Fecal Occult Blood Testing and Sigmoidoscopy Compared with Primary Colonoscopy Screening for Colorectal Advanced Adenomas

  2011cited by this paper
• Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE.

  2011cited by this paper
• Sensitivity of immunochemical faecal occult blood testing for detecting left- vs right-sided colorectal neoplasia

  2011cited by this paper
• Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial.

  2010cited by this paper
• Comparison of Guaiac-Based and Quantitative Immunochemical Fecal Occult Blood Testing in a Population at Average Risk Undergoing Colorectal Cancer Screening

  2010cited by this paper
• Low-dose aspirin use and performance of immunochemical fecal occult blood tests.

  2010cited by this paper
• Comparative Evaluation of Immunochemical Fecal Occult Blood Tests for Colorectal Adenoma Detection

  2009cited by this paper
• Combination of sigmoidoscopy and a fecal immunochemical test to detect proximal colon neoplasia.

  2009cited by this paper
• False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening

  2009cited by this paper
• Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy

  2009cited by this paper
• Miss rate for colorectal neoplastic polyps: a prospective multicenter study of back-to-back video colonoscopies

  2008cited by this paper
• Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population

  2008cited by this paper
• Immunologic Fecal Occult Blood Test for Colorectal Cancer Screening

  2006cited by this paper
• Performance Characteristics and Evaluation of an Automated-Developed and Quantitative, Immunochemical, Fecal Occult Blood Screening Test

  2005cited by this paper
• A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.

  2005cited by this paper

• Stool- and Blood-Associated Colorectal Cancer Biomarkers: A Systematic Review

  2025cites this paper
• Utility of quantitative fecal immunochemical test values for average risk colorectal cancer screening risk stratification among patients with a positive test.

  2025cites this paper
• Anatomical location of colorectal neoplasia in patients with positive stool tests (mt-sDNA or FIT): Data from the New Hampshire Colonoscopy Registry.

  2025cites this paper
• Anatomical Distribution of Polyps Is Different for Men and Women With Positive Stool Tests

  2025cites this paper
• Adenoma location, size, and morphology are risk factors for FOBT false-negative results in inpatients with advanced colorectal adenoma

  2024cites this paper
• Antithrombotic drug use does not affect the fecal immunochemical test PPV for colorectal cancer, but warfarin may have an impact in a Japanese cohort

  2023cites this paper
• Interval colorectal cancers after negative faecal immunochemical test in the New Zealand Bowel Screening Pilot

  2023cites this paper
• American Indian/Alaska Native and black colon cancer patients have poorer cause-specific survival based on disease stage and anatomic site of diagnosis

  2022cites this paper
• Calibrating Natural History of Cancer Models in the Presence of Data Incompatibility: Problems and Solutions

  2022cites this paper
• Faecal Immunochemical Test Impact on Prognosis of Colorectal Cancer Detected in Symptomatic Patients

  2022cites this paper
• Development and Validation of Three Regional Microsimulation Models for Predicting Colorectal Cancer Screening Benefits in Europe

  2021cites this paper
• Divergent detection rates of fecal immunochemical test and questionnaire-based risk assessment for detecting proximal and distal advanced colorectal adenomas

  2021cites this paper
• Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

  2021cites this paper
• Using Comorbidity Pattern Analysis to Detect Reliable Methylated Genes in Colorectal Cancer Verified by Stool DNA Test

  2021cites this paper
• Consistent Major Differences in Sex- and Age-Specific Diagnostic Performance among Nine Faecal Immunochemical Tests Used for Colorectal Cancer Screening

  2021cites this paper
• Tracking the Antibody Immunome in Sporadic Colorectal Cancer by Using Antigen Self-Assembled Protein Arrays

  2021cites this paper
• PPV and Detection Rate of mt-sDNA, FIT, and CT Colonography for Advanced Neoplasia: A Hierarchical Bayesian Meta-Analysis of the Noninvasive Colorectal Screening Tests.

  2021cites this paper
• Correlation of Fecal Immunochemical Testing Levels With Pathology Results in a National Colorectal Cancer Screening Program

  2021cites this paper
• Stool-Based Tests for Colorectal Cancer Screening: Performance Benchmarks Lead to High Expected Efficacy

  2020cites this paper
• Interval colorectal cancers after negative faecal immunochemical test in a 13-year screening programme

  2020cites this paper
• Sensitivity of fecal immunochemical test for colorectal cancer detection differs according to stage and location.

  2020cites this paper
• Characteristics of Advanced Colorectal Cancer Detected by Fecal Immunochemical Test Screening in Participants with a Negative Result the Previous Year.

  2020cites this paper
• Triage May Improve Selection to Colonoscopy and Reduce the Number of Unnecessary Colonoscopies

  2020cites this paper
• Black and White Differences in Colorectal Cancer Screening and Screening Outcomes: A Narrative Review

  2020cites this paper
• Factors affecting patient adherence to publicly funded colorectal cancer screening programmes: a systematic review.

  2020cites this paper
• CLEP_A_213677 943..954

  2019cites this paper
• Diagnostic Accuracy Of Fecal Occult Blood Tests For Detecting Proximal Versus Distal Colorectal Neoplasia: A Systematic Review And Meta-Analysis

  2019cites this paper
• Stage-Specific Sensitivity of Fecal Immunochemical Tests for Detecting Colorectal Cancer: Systematic Review and Meta-Analysis

  2019influential citation
• Effect of Sex, Age and Positivity Threshold on Fecal Immunochemical Test Accuracy: a Systematic Review and Meta-Analysis.

  2019cites this paper
• Performance Characteristics of Fecal Immunochemical Tests for Colorectal Cancer and Advanced Adenomatous Polyps

  2019cites this paper
• Colorectal cancer screening: The surgery rates they are a-changing. A nationwide study on surgical resections in Italy.

  2019cites this paper
• Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection

  2018cites this paper
• Flexible sigmoidoscopy in colorectal cancer screening: implications of different colonoscopy referral strategies

  2018cites this paper
• Participant‐Related Risk Factors for False‐Positive and False‐Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta‐Analysis

  2018cites this paper
• UEG Week 2018 Poster Presentations

  2018cites this paper
• Modeling in Colorectal Cancer Screening: Assessing External and Predictive Validity of MISCAN-Colon Microsimulation Model Using NORCCAP Trial Results

  2018cites this paper
• Fecal immunochemical test for hemoglobin in combination with fecal transferrin in colorectal cancer screening

  2018cites this paper
• Divergent Long-Term Detection Rates of Proximal and Distal Advanced Neoplasia in Fecal Immunochemical Test Screening Programs

  2018cites this paper
• Clinical trial protocol of the ASTER trial: a double-blind, randomized, placebo-controlled phase III trial evaluating the use of acetylsalicylic acid (ASA) for enhanced early detection of colorectal neoplasms

  2018cites this paper
• Diagnostic Performance of One-off Flexible Sigmoidoscopy with Fecal Immunochemical Testing in a Large Screening Population

  2017cites this paper
• Distribution of colorectal polyps: Implications for screening.

  2017cites this paper
• Selecting a Cut-off for Colorectal Cancer Screening With a Fecal Immunochemical Test

  2017cites this paper